Publication | Open Access

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

Cannabis UseNeurophysiologyNeuroanatomyEndocannabinoid LevelsMedicinePharmacologyNeuropharmacologyRat ModelNeurologyNeuroscienceMultiple SclerosisNeuroimmunologyNeurochemistryCannabinoidsSocial SciencesCannabis